Main menu
  1. Home
  2.  » 
  3. Events
  4.  » Navigating Your Biopharma Drug Candidate Through Early and Mid-Stage Clinical Trials

Navigating Your Biopharma Drug Candidate Through Early and Mid-Stage Clinical Trials

Date: Tuesday, February 8, 2022
Time: 11 a.m. EST

Decisions made throughout early and mid-stage clinical trials impact late-stage results and sometimes, entire programs and companies. Since some obstacles can prove overwhelming for startups, there is a lot to learn from those who successfully walked the path.

In this Endpoints News Webinar, we assembled a panel of experts to weigh in on:

  • Gathering the right team to translate benchtop discoveries into clinical trials
  • Choosing the right study design to position phase 1 safety data for phase 2 efficacy trials
  • Planning clinical operations to manage diverse internal and external stakeholders
  • CMC strategies to help drug products reach patients faster

FEATURED SPEAKER

Meredith Perry
Director, Pharmaceutics
Catalent

 

MODERATOR

Arsalan Arif
Founder & Publisher
Endpoints News